Pathology of cardiovascular interventions and surgery

Diagnostic Histopathology

Volumn 16, Issue 1, 2010, Pages 17-30

  Li, Alice Y ^a   Law, Kelsey B ^a   Phillips, Katharine R B ^a   Nwachukwu, Harriet ^a   Butany, Jagdish ^a   Gotlieb, Avrum I ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

aneurysms; angioplasty; coronary artery disease; endomyocardial biopsies; endovascular repair; prosthetic vascular grafts; stem cells; stents; ventricular assist devices

Indexed keywords

AORTA ANEURYSM; AORTA DISSECTION; AORTA SURGERY; ARTERIOVENOUS SHUNT; ARTERY SURGERY; ARTICLE; ASSISTED CIRCULATION; ATHEROSCLEROSIS; BLOOD VESSEL PROSTHESIS; CARDIOVASCULAR SURGERY; CLINICAL FEATURE; CORONARY ARTERY SURGERY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; SAPHENOUS VEIN GRAFT; VEIN BYPASS; VEIN GRAFT;

EID: 74149092045     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.10.003     Document Type: Article

References (58)

1. Gotlieb A.I. In: Rubin R., and Strayer D. (Eds). Blood vessels in Rubin's pathology. 5th edn (2007), Lippincott, Williams and Wilkins 397-426
2. Cunningham K., and Gotlieb A.I. The role of shear stress in atherogenesis. Lab Invest 85 (2005) 9-23
3. Hyduk S.J., and Cybulsky M.I. Role of alpha4beta1 integrins in chemokine-induced monocyte arrest under conditions of shear stress. Microcirculation 16 (2009) 17-30
4. Davi G., and Patrono C. Platelet activation and atherothrombosis. N Engl J Med 357 (2007) 2482-2494
5. Blair P., and Flaumenhaft R. Platelet alpha granules: basic biology and clinical correlates. Blood Rev 23 (2009) 177-189
6. Singh N.N., and Ramji D.P. The role of TGF-β in atherosclerosis. Cytokine Growth Factor Rev 17 (2006) 487-499
7. Adiguzel E., Ahmad P.J., Franco C., and Bendeck M.P. Collagen in the progression and complications of atherosclerosis. Vasc Med 14 (2009) 73-89
8. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15 (1995) 1512-1531
9. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. Am J Coll Cardiol 47 (2006) C13-C18
10. Gruntzig A.R., Senning A., and Seigenthaler W.E. Nonoperative dilatation of coronary-artery stenosis: precutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
11. Metha S.R., Cannon C.P., Fox K.A., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
12. Trikalinos T.A., Alsheikh-Ali A.A., Tatsioni A., Nallamothu B.K., and Kent D.M. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta analysis. Lancet 373 (2009) 911-918
13. Boam A.B. Regulatory issues facing the development of drug eluting stents: a US FDA perspective. Expert Rev Med Devices 3 (2006) 297-300
14. Soran O., Manchanda A., and Schueler S. Precutaneous coronary intervention vs coronary artery bypass surgery in multivessel disease: a current perspective. Interact Cardiovasc Thorac Surg 8 (2009) 666-671
15. Park D.-W., Yun S.-C., Lee S.-W., et al. Long-term mortality after precutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117 (2008) 2079-86
16. Colombo A. Bifurcation lesions. Ital Heart J 6 (2005) 475-488
17. Rippstein P., Black M.K., Boivin M., et al. Comparison of processing and sectioning methodologies for arteries containing metallic stents. J Histochem Cytochem 54 (2006) 673-681
18. Bradshaw S.H., Kennedy L., Dexter D.F., and Veinot J.P. A practical method to rapidly dissolve metallic stents. Cardiovasc Pathol 18 (2009) 127-133
19. Carter A.J., Farb A., Gould K.E., Taylor A.J., and Virmani R. The degree of neointimal formation after stent placement in atherosclerotic rabbit iliac arteries is dependent on the underlying plaque. Cardiovasc Pathol 8 (1999) 73-80
20. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
21. Steffel J., Latini R.A., Akhemdova, et al. Rapamycin, but not FK-506, increases endothelial tissue factor expressión: implications for drug-eluting stent design. Circulation 112 (2005) 2002-2011
22. Nakazawa G., Finn A.V., Kolodgie F.D., and Virmani R. A review of current devices and a look at new technology: durg-eluting stents. Expert Rev Med Devices 6 (2009) 33-42
23. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
24. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
25. Ge L., Airoldi F., Iakovou I., and Virmani R. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post dilation. J Am Coll Cardiol 46 (2005) 613-620
26. Nakazawa G., Ladich E., Finn A.V., and Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury. EuroIntervention Suppl C (2008) C7-10
27. Virmani R., Ursell P.C., and Fenoglio J.J. Examination of the heart. Hum Pathol 18 (1987) 432-440
28. Ribichini F., Pugno F., Ferrero V., et al. Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts. Clin Sci 114 (2008) 211-220
29. Ricco J.B., Marchand C., Neau J.P., Marchand E., Cau J., and Fébrer G. Prosthetic carotid bypass grafts for atherosclerotic lesions: a prospective study of 198 consecutive cases. Eur J Vasc Endovasc Surg 37 (2009) 272-287
30. Dobrin P.B., Mirande R., Kang S., Sheng D.Q., and Mrkvicka R. Mechanics of end-to-end artery-to-PTFE graft anastomoses. Ann Vasc Surg 12 (1998) 317-323
31. ® vs. PTFE as bypass materials in peripheral vascular surgery - systematic review and meat-analysis. BMC Surg 8 (2008) 22
32. Aavik A., Lieberg J., Kals J., Pulges A., Kals M., and Lepner U. Ten years experience of treating aorto-femoral bypass graft infection with venous allografts. Eur J Vasc Endovasc Surg 36 (2008) 432-437
33. Olofsson P., Rabahie G.N., Matsumoto K., et al. Histopathological characteristics of explanted human prosthetic arterial grafts: implications for the prevention and management of graft infection. Eur J Vasc Endovasc Surg 9 (1995) 143-151
34. Ailawadi G., Eliason J.L., and Upchurch Jr. G.R. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 38 (2003) 584-588
35. Davies M.J. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 98 (1998) 193-195
36. Coady M.A., et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 134 (1999) 361-367
37. Nesi G., Anichini C., Tozzini S., Boddi V., Calamai G., and Gori F. Pathology of the thoracic aorta: a morphologic review of 338 surgical specimens over a 7-year period. Cardiovasc Pathol 18 (2009) 134-139
38. Motro M., Fisman E.Z., and Tenenbaum A. Cardiovascular management of Marafan syndrome. IMAJ 10 (2008) 182-185
39. Adam D.J., Mohan I.V., Stuart W.P., Bain M., and Bradbury A.W. Community and hospital outcome from ruptured abdominal aortic aneurysm within the catchment area of a regional vascular surgical service. J Vasc Surg 30 (1999) 922-928
40. Brown L.C., Epstein D., Manca A., Beard J.D., Powell J.T., and Greenhalgh R.M. The UK Endovascular Aneurysm Repair (EVAR) trials: design, methodology and progress. Eur J Vasc Endovasc Surg 27 (2004) 372-381
41. Prinssen M., Buskens E., and Blankensteijn J.D. The Dutch Randomised Endovascular Aneurysm Management (DREAM) trial. Background, design and methods. J Cardiovasc Surg (Torino) 43 (2002) 379-384
42. EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365 (2005) 2179-2186
43. Blankensteijn J.D., et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 352 (2005) 2398-2405
44. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
45. Hamour I.M., Burke M.M., Bell A.D., Panicker M.G., Banerjee R., and Banner N.R. Limited utility of endomyocardial biopsy in the first year after heart transplantation. Transplantation 85 (2008) 969-974
46. Luk A., Metawee M., Ahn E., Gustafsson F., Ross H., and Butany J. Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy. Can J Cardiol 25 (2009) e48-e54
47. Cunningham K.S., Veinot J.P., and Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol 59 (2006) 121-129
48. Karatolios K., Pankuweit S., and Maisch B. Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr Treat Options Cardiovasc Med 9 (2007) 473-481
49. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50 (2007) 1914-1931
50. Holzmann M., Nicko A., Kuhl U., et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118 (2008) 1722-1728
51. Nguyen V., Cantarovich M., Cecere R., and Giannetti N. Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many?. J Heart Lung Transplant 24 (2005) S227-S231
52. Drakos S.G., Charitos E.I., Nanas S.N., and Nanas J.N. Ventricular-assist devices for the treatment of chronic heart failure. Expert Rev Cardiovasc Ther 5 (2007) 571-584
53. Maybaum S., Kamalakannan G., and Murthy S. Cardiac recovery during mechanical assist device support. Semin Thorac Cardiovasc Surg 20 (2008) 234-246
54. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
55. Bruggink A.H., van Oosterhout M.F., de Jonge N., et al. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 25 (2006) 1091-1098
56. Barnes K. Complications in patients with ventricular assist devices. Dimens Crit Care Nurs 27 (2008) 233-241 quiz 242-3
57. Rose A.G., and Park S.J. Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts. Cardiovasc Pathol 14 (2005) 19-23
58. Khan N.A., Butany J., Zhou T., Ross H.J., and Rao V. Pathological findings in explanted prosthetic heart valves from ventricular assist devices. Pathology 40 (2008) 377-384